1. Home
  2. CTSO vs ABVC Comparison

CTSO vs ABVC Comparison

Compare CTSO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

SELL

Current Price

$6.01

Market Cap

23.9M

Sector

Health Care

ML Signal

SELL

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

HOLD

Current Price

$1.05

Market Cap

26.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
ABVC
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
26.1M
IPO Year
2008
2009

Fundamental Metrics

Financial Performance
Metric
CTSO
ABVC
Price
$6.01
$1.05
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $12.25
N/A
AVG Volume (30 Days)
52.9K
★ 60.0K
Earning Date
11-12-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.79
7.14
EPS
N/A
★ N/A
Revenue
★ $22,503,908.00
$509,589.00
Revenue This Year
$4.91
N/A
Revenue Next Year
$13.58
$171.50
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 48.53
N/A
52 Week Low
$0.30
$0.71
52 Week High
$7.44
$3.06

Technical Indicators

Market Signals
Indicator
CTSO
ABVC
Relative Strength Index (RSI) 73.08 52.02
Support Level $2.88 $1.00
Resistance Level $7.44 $1.14
Average True Range (ATR) 0.61 0.06
MACD 0.19 -0.00
Stochastic Oscillator 82.52 72.94

Price Performance

Historical Comparison
CTSO
ABVC

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Share on Social Networks: